These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 26302060

  • 1. Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson's disease.
    Liu W, Li Y, Jalewa J, Saunders-Wood T, Li L, Hölscher C.
    Eur J Pharmacol; 2015 Oct 15; 765():284-90. PubMed ID: 26302060
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Liu W, Jalewa J, Sharma M, Li G, Li L, Hölscher C.
    Neuroscience; 2015 Sep 10; 303():42-50. PubMed ID: 26141845
    [Abstract] [Full Text] [Related]

  • 3. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
    Ji C, Xue GF, Lijun C, Feng P, Li D, Li L, Li G, Hölscher C.
    Brain Res; 2016 Mar 01; 1634():1-11. PubMed ID: 26453833
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson's disease mouse model.
    Zhang Y, Chen Y, Li L, Hölscher C.
    Behav Brain Res; 2015 Oct 15; 293():107-13. PubMed ID: 26187689
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model.
    Zhang L, Zhang L, Li L, Hölscher C.
    Neuropeptides; 2018 Oct 15; 71():70-80. PubMed ID: 30017231
    [Abstract] [Full Text] [Related]

  • 6. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
    Jalewa J, Sharma MK, Gengler S, Hölscher C.
    Neuropharmacology; 2017 May 01; 117():238-248. PubMed ID: 28223210
    [Abstract] [Full Text] [Related]

  • 7. A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain.
    Cao L, Li D, Feng P, Li L, Xue GF, Li G, Hölscher C.
    Neuroreport; 2016 Apr 13; 27(6):384-91. PubMed ID: 26918675
    [Abstract] [Full Text] [Related]

  • 8. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
    Bao XQ, Wu LY, Wang XL, Sun H, Zhang D.
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May 13; 388(5):549-56. PubMed ID: 25678053
    [Abstract] [Full Text] [Related]

  • 9. Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease.
    Feng P, Zhang X, Li D, Ji C, Yuan Z, Wang R, Xue G, Li G, Hölscher C.
    Neuropharmacology; 2018 May 01; 133():385-394. PubMed ID: 29462693
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J, Carrillo-S C, García E, Ruiz-Mar G, Pérez-Tamayo R, Chavarría A.
    Toxicology; 2014 May 07; 319():38-43. PubMed ID: 24607817
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb 07; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

  • 12. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY, Lee JE, Park JH, Shin IC, Koh HC.
    Toxicol Lett; 2012 Sep 18; 213(3):332-44. PubMed ID: 22842585
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
    Zhang L, Huang L, Chen L, Hao D, Chen J.
    Toxicol Lett; 2013 Oct 24; 222(2):155-63. PubMed ID: 23911879
    [Abstract] [Full Text] [Related]

  • 14. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S, Moon M, Park S.
    J Endocrinol; 2009 Sep 24; 202(3):431-9. PubMed ID: 19570816
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
    Yang W, Chen YH, Liu H, Qu HD.
    Int J Mol Med; 2015 Nov 24; 36(5):1369-76. PubMed ID: 26648012
    [Abstract] [Full Text] [Related]

  • 16. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S, Ranju V, Kalaivani P, Priya RJ, Sumathy H, Sunil AG, Babu CS.
    Neuropharmacology; 2013 Oct 24; 73():98-110. PubMed ID: 23747572
    [Abstract] [Full Text] [Related]

  • 17. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism.
    Park G, Park YJ, Yang HO, Oh MS.
    Pharmacol Biochem Behav; 2013 Mar 24; 104():163-8. PubMed ID: 23369986
    [Abstract] [Full Text] [Related]

  • 18. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
    Yuan Z, Li D, Feng P, Xue G, Ji C, Li G, Hölscher C.
    Eur J Pharmacol; 2017 Oct 05; 812():82-90. PubMed ID: 28666800
    [Abstract] [Full Text] [Related]

  • 19. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU.
    J Neurochem; 2015 May 05; 133(4):590-7. PubMed ID: 25581060
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.
    Li Y, Liu W, Li L, Hölscher C.
    Neuropharmacology; 2016 Feb 05; 101():255-63. PubMed ID: 26453962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.